发明名称 |
MANNOSE BINDING LECTIN AND USES THEREOF |
摘要 |
The present inventors have shown that MASP-depleted MBL is able to recruit MASPs from plasma and successfully activate the complement cascade. Furthermore, it has been discovered that MBL purified as a complex has limit ed ability to activate the complement cascade when compared to MASP-depleted MB L. Accordingly, the present invention provides a pharmaceutical composition comprising an isolated non-recombinant mannose binding lectin (MBL) substantially free from activated MBL associated serine proteases (MASPs) together with a pharmaceutically acceptable carrier or diluent. Also provide d is a method of treating a subject in need of MBL comprising administering to the subject an effective amount of a pharmaceutical composition of the invention.
|
申请公布号 |
CA2483441(A1) |
申请公布日期 |
2003.11.06 |
申请号 |
CA20032483441 |
申请日期 |
2003.04.24 |
申请人 |
THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH |
发明人 |
O'BRIEN, GRACE;MINCHINTON, ROBYN MYRA;MARTINELLI, TERESA MARION;DEAN, MELINDA MARGARET;PIKE, ROBERT NEIL |
分类号 |
C12Q1/37;A61K35/14;A61K38/17;A61K38/36;A61P31/00;A61P31/04;A61P31/12;A61P33/00;A61P35/02;A61P37/04;C07K14/47;(IPC1-7):A61K38/17;A61K38/08 |
主分类号 |
C12Q1/37 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|